DK0527646T3 - Hidtil ukendte forbindelser benævnt adenophostiner, deres fremstilling og deres therapeutiske anvendelse - Google Patents

Hidtil ukendte forbindelser benævnt adenophostiner, deres fremstilling og deres therapeutiske anvendelse

Info

Publication number
DK0527646T3
DK0527646T3 DK92307387.8T DK92307387T DK0527646T3 DK 0527646 T3 DK0527646 T3 DK 0527646T3 DK 92307387 T DK92307387 T DK 92307387T DK 0527646 T3 DK0527646 T3 DK 0527646T3
Authority
DK
Denmark
Prior art keywords
adenophostins
preparation
therapeutic use
new compounds
compounds known
Prior art date
Application number
DK92307387.8T
Other languages
Danish (da)
English (en)
Inventor
Shuji Takahashi
Masaaki Takahashi
Kazuhiko Tanzawa
Kaneo Ogawa
Tsuyoshi Hosoya
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0527646T3 publication Critical patent/DK0527646T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK92307387.8T 1991-08-14 1992-08-12 Hidtil ukendte forbindelser benævnt adenophostiner, deres fremstilling og deres therapeutiske anvendelse DK0527646T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20408991 1991-08-14

Publications (1)

Publication Number Publication Date
DK0527646T3 true DK0527646T3 (da) 1997-10-13

Family

ID=16484606

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92307387.8T DK0527646T3 (da) 1991-08-14 1992-08-12 Hidtil ukendte forbindelser benævnt adenophostiner, deres fremstilling og deres therapeutiske anvendelse

Country Status (10)

Country Link
US (1) US5436231A (de)
EP (1) EP0527646B1 (de)
JP (1) JP2750239B2 (de)
AT (1) ATE150762T1 (de)
CA (1) CA2076060C (de)
DE (1) DE69218517T2 (de)
DK (1) DK0527646T3 (de)
ES (1) ES2102466T3 (de)
GR (1) GR3023824T3 (de)
HK (1) HK1005737A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097713A1 (de) 1999-11-03 2001-05-09 Euroscreen S.A. Inhibitoren von Inositol-Phosphatase ship-2 Moleküle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2509531A1 (de) * 1975-03-05 1976-09-16 Thomae Gmbh Dr K Antivirales mittel
EP0249873B1 (de) * 1986-06-16 1993-07-28 Daiichi Pharmaceutical Co., Ltd. Therapeutisches Mittel für Hautgeschwüre
US5049550A (en) * 1987-11-05 1991-09-17 Worcester Foundation For Experimental Biology Diadenosine 5', 5'"-p1, p4,-tetraphosphate analogs as antithrombotic agents
JPH01308231A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 安定化された医薬組成物および製造法
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel

Also Published As

Publication number Publication date
GR3023824T3 (en) 1997-09-30
JPH05194580A (ja) 1993-08-03
DE69218517T2 (de) 1997-11-13
JP2750239B2 (ja) 1998-05-13
CA2076060C (en) 2002-08-06
DE69218517D1 (de) 1997-04-30
CA2076060A1 (en) 1993-02-15
HK1005737A1 (en) 1999-01-22
ES2102466T3 (es) 1997-08-01
US5436231A (en) 1995-07-25
ATE150762T1 (de) 1997-04-15
EP0527646B1 (de) 1997-03-26
EP0527646A1 (de) 1993-02-17

Similar Documents

Publication Publication Date Title
ES2143526T3 (es) Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos.
PH25859A (en) Composition for treatment of ischemic disorder
ATE132150T1 (de) 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen
AU588972B2 (en) New derivatives of 1,2,5,6-tetrahydropyridine-3- carboxaldehyde oxime, their preparation process, their use as medicaments, and the compositions containing them
GEP19960656B (en) Method for production of phenylalkylamines or its pharmaceutically acceptable salts
CA2134211A1 (en) Use of Terfenadine Derivatives as Antihistaminics in a Hepatically Impaired Patient
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
FI893701A0 (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
ATE114465T1 (de) Pharmazeutische zusammensetzung zur inhibierung der knochenresorption.
HUT61763A (en) Process for producing xanthine derivatives and pharmaceutical compositions comprising same as active ingredient, against disorders of cerebration
AU6802490A (en) Novel 2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)thiazoles, processes for their preparation, pharmaceuticals containing them and their use
DK0527646T3 (da) Hidtil ukendte forbindelser benævnt adenophostiner, deres fremstilling og deres therapeutiske anvendelse
NO171362C (no) Analogifremgangsmaate for fremstilling av nye aralkylaminforbindelser og deres salter
NO843296L (no) Fremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet
EP0385446A3 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten
GB9510858D0 (en) Process for preparing lipoic acid
ES2180972T3 (es) Composicion contra el helicobacter pilori que contiene derivados de 1-metilcarbapenem como ingrediente activo.
ES2054011T3 (es) Un proceso para la preparacion de un compuesto, "leualacina".
HUT71112A (en) Pharmaceutical composition for prophylaxis and treatment of myopia containing benzopyrano pyridin derivatives
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
FR2456100A1 (fr) Procede pour la preparation de composes du type pyrimidine condensee a tete de pont azotee, leurs sels, hydrates et isomeres, certains representants des composes prepares et compositions pharmaceutiques les contenant
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
ATE87301T1 (de) N-acyl-n-naphthoylglycine als aldose-reductaseinhibitoren.
PH30180A (en) Leustroducsin h its preparation and its therapeutic use
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.